Aminex Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-05.
Aminex Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on December 5, 2025. The filing reports $15.08M sold. Its industry group is Biotechnology. It names David Meeks (Director), Mark Burns (Executive Officer, Director), Don Dyer (Director) (SEC Form D, December 5, 2025).
Sell to companies like Aminex Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-12-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Aminex Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Aminex Therapeutics, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Aminex Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Aminex Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Aminex Therapeutics, Inc. →Get the full cited report on Aminex Therapeutics, Inc.
What the filing shows about Aminex Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aminex Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Aminex Therapeutics, Inc. See pricing
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $15.08M, on the same scale — one filing against the whole group's total, so it sits low by construction.
David Meeks is named as Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
Mark Burns is named as Executive Officer and Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
Don Dyer is named as Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
Jeffrey Miller is named as Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
Deyaa Adib is named as Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
James Skaggs is named as Director on the Form D that Aminex Therapeutics, Inc. filed with the SEC on 5 December 2025, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2025-12-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Aminex Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aminex Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aminex Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Aminex Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Aminex Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Aminex Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/aminex-therapeutics-inc-form-d-25000001